Effect of Repeated Intranasal Administration of Different Doses of Insulin on Postoperative Delirium, Serum τ and Aβ Protein in Elderly Patients Undergoing Radical Esophageal Cancer Surgery
Qingqing Huang,Qin Shi,Xiaobo Yi,Jingzheng Zeng,Xuemei Dai,Lu Lin,Yanling Yang,Xiao Wu,Gu Gong
DOI: https://doi.org/10.2147/NDT.S405426
IF: 2.989
2023-04-28
Neuropsychiatric Disease and Treatment
Abstract:Qingqing Huang, 1 Qin Shi, 2 Xiaobo Yi, 1 Jingzheng Zeng, 2 Xuemei Dai, 1 Lu Lin, 1 Yanling Yang, 1 Xiao Wu, 2 Gu Gong 1 1 Department of Anesthesiology, The General Hospital of Western Theater Command, Chengdu, People's Republic of China; 2 Department of Anesthesiology, North Sichuan Medical College, Nanchong, People's Republic of China Correspondence: Gu Gong, Department of Anesthesiology, The General Hospital of Western Theater Command, 270 Tianhui Road, Rongdu Avenue, Jinniu District, Chengdu, Sichuan, 610083, People's Republic of China, Tel +8617360137572, Fax +86 28570423, Email Objective: Postoperative delirium is common after general anesthesia in older patients. However, there are currently no effective preventive measures. This study investigated the effect of repeated intranasal administration of different insulin doses before surgery on postoperative delirium in older patients with esophageal cancer, and the possible mechanism for its efficacy. Methods: In this randomized, placebo-controlled, double-blind, parallel-group study, 90 older patients were randomly assigned to either a Control (normal saline), Insulin 1 (20 U/0.5 mL intranasal insulin), or Insulin 2 (30 U/0.75 mL intranasal insulin) group. Delirium was assessed on postoperative days 1 (T2), 2 (T3), and 3 (T4) using the Confusion Assessment Method for the Intensive Care Unit. Serum τ and Aβ protein levels were measured at T0 (before insulin/saline administration), T1 (end of surgery), T2, T3 and T4. Results: The Insulin 2 group had a significantly lower prevalence of delirium compared to the Control and Insulin 1 groups three days after surgery. Compared to baseline, τ and Aβ protein levels increased significantly at T1–T4. Compared to the Control group, the Insulin 1 and 2 groups had significantly lower τ and Aβ protein levels at T1–T4, and the Insulin 2 group had significantly lower levels than the Insulin 1 group at T1–T2. Conclusion: The administration of 30 U of intranasal insulin twice daily, from 2 days preoperatively until 10 minutes preanesthesia on the day of surgery, can significantly reduce postoperative delirium in older patients undergoing radical esophagectomy. It can also decrease postoperative τ and Aβ protein expression without causing hypoglycemia. Clinical Trial Registration: This study was registered at the Chinese Clinical Trial Registry ( www.chictr.org.cn , with the unique identifier: ChiCTR2100054245; December 11, 2021). Keywords: postoperative delirium, intranasal insulin, τ protein, Aβ protein, aged Postoperative delirium (POD) is a common postoperative complication in older patients undergoing surgery, and its prevalence can reach 50% after esophageal cancer surgery. 1 Its main manifestations are disordered thinking, disorientation, inattention, day and night reversal, and altered consciousness. POD can lead to increased postoperative complications and perioperative mortality. 2 Currently, the pathogenesis of POD is unclear and there is no safe and effective method for its prevention and treatment. Intranasal insulin administration is an important treatment for the cognitive impairment associated with abnormal brain energy metabolism, and has received extensive attention recently. 3–5 Following its intranasal administration, insulin can quickly reach the central cerebrospinal fluid through the cerebral ventricular system around the olfactory nerve in the nasal cavity. This method allows insulin to bypass the blood–brain barrier, leading to higher levels in the brain. Thus, intranasal administration can effectively prevent the adverse effects of peripheral administration, such as hypoglycemia. 6 Shpakov et al 7 showed that insulin has a unique effect after binding to different insulin receptors in the brain, and could be used for treatment of cerebral ischemia, traumatic brain injuries, and postoperative delirium (after anesthesia), as well as diabetes mellitus and its complications such as dysfunctions in the gonadal and thyroid axes. Our previous study indicated that repeated administration of intranasal insulin could reduce the prevalence of POD and tumor necrosis factor-α, interleukin-1β, and interleukin-6 levels in elderly patients after laparoscopic radical gastrointestinal tumor resection. 8 Meanwhile, existing studies suggest that total τ protein and Aβ protein may be potential biomarkers for postoperative delirium. 9,10 However, there are no studies on the effect of repeated intranasal administration of different insulin doses on POD. This study investigated the effect of repeated intranasal administration of dif -Abstract Truncated-
psychiatry,clinical neurology